Actively Recruiting

Age: 18Years +
All Genders
NCT06341062

The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU

Led by Peking University Third Hospital · Updated on 2025-02-17

44

Participants Needed

1

Research Sites

115 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this study is to quantitatively assess renal microcirculation changes by contrast-enhanced ultrasound and to obtain systemic hemodynamic information by ultrasound Doppler at the same time, to analyze the relationship between renal microcirculation changes and systemic hemodynamic changes, and to explore its predictive value in renal function recovery in patients with critical acute kidney injury. The main questions it aims to answer are: 1. To explore the quantitative parameters of contrast-enhanced ultrasound which can reflect the changes of renal microcirculation. 2. To explore the relationship between renal microcirculation and systemic hemodynamics. 3. To explore the value of renal microflow changes quantitatively evaluated by contrast-enhanced ultrasound in predicting renal function recovery.

CONDITIONS

Official Title

The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age >18 years old
  • Acute kidney injury diagnosed less than 24 hours after first admission to intensive care unit (ICU)
  • Expected length of stay in ICU at least 48 hours
  • Meet Kidney Disease Improving Global Outcomes (KDIGO) 2012 diagnostic criteria for acute kidney injury
  • Contrast-enhanced ultrasound performed within 24 hours after AKI diagnosis
Not Eligible

You will not qualify if you...

  • Known severe chronic kidney disease (stage 4 or higher) or undergoing hemodialysis treatment
  • History of kidney transplantation or renal cancer
  • Terminal stage of malignant tumor
  • Pregnancy
  • Renal artery stenosis or renal vein thrombosis
  • Allergy to contrast agent SonoVue or its components
  • Severe cardiopulmonary insufficiency such as right-to-left shunt heart disease or pulmonary systolic blood pressure over 90 mmHg

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Ultrasound Diagnosis, Peking University Third Hospital

Beijing, Beijing Municipality, China

Actively Recruiting

Loading map...

Research Team

Y

Yuewei Zhang, Dr

CONTACT

L

Ligang Cui, Dr

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU | DecenTrialz